We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XRN
2176
Chiron Real Estate Inc
XRN
$535M
$740K ﹤0.01%
15,603
-1,216
-7% -$55K
DMYS.WS
2177
CALL
DELISTED
dMY Technology Group, Inc. VI Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
DMYS.WS
$738K ﹤0.01%
73,433
SZZL
2178
DELISTED
Sizzle Acquisition Corp. Common stock
SZZL
$735K ﹤0.01%
71,919
-115,072
-62% -$1.17M
SKIL.WS
2179
CALL
DELISTED
Skillsoft Corp. Warrants, each whole warrant is exercisable for 1/20th of a share of Class A Common Stock at an exercise price of $230.00
SKIL.WS
$734K ﹤0.01%
564,480
-5,520
-1% -$714
AREC icon
2180
American Resources Corp
AREC
$183M
$733K ﹤0.01%
555,628
+387,375
+230% +$708K
CHCO icon
2181
City Holding Co
CHCO
$2.05B
$730K ﹤0.01%
+7,844
New +$755K
UHGWW
2182
CALL
DELISTED
United Homes Group Warrant
UHGWW
$729K ﹤0.01%
72,512
KEN icon
2183
Kenon Holdings
KEN
$3.33B
$729K ﹤0.01%
22,090
-8,460
-28% -$305K
UMBF icon
2184
UMB Financial
UMBF
$11.3B
$727K ﹤0.01%
8,700
-9,810
-53% -$824K
SRCL
2185
DELISTED
Stericycle Inc
SRCL
$726K ﹤0.01%
14,552
+7,924
+120% +$377K
NUS icon
2186
Nu Skin
NUS
$257M
$725K ﹤0.01%
17,189
-278
-2% -$10.7K
COOK icon
2187
Traeger
COOK
$165M
$722K ﹤0.01%
5,118
+4,453
+670% +$744K
TFC icon
2188
CALL
Truist Financial
TFC
$63.9B
$719K ﹤0.01%
+16,700
New +$733K
SRTAW
2189
CALL
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
$716K ﹤0.01%
200,000
-214,666
-52% -$137K
CLINW
2190
CALL
DELISTED
Clean Earth Acquisitions Corp. Warrant
CLINW
$711K ﹤0.01%
70,431
-156,691
-69% -$13.8K
ZBH icon
2191
Zimmer Biomet
ZBH
$18.8B
$711K ﹤0.01%
+5,579
New +$647K
CCRD
2192
DELISTED
CoreCard
CCRD
$711K ﹤0.01%
24,548
-14,271
-37% -$374K
IPGP icon
2193
IPG Photonics
IPGP
$3.4B
$710K ﹤0.01%
7,499
-34,906
-82% -$3.13M
ABNB icon
2194
PUT
Airbnb
ABNB
$90.8B
$710K ﹤0.01%
8,300
-277,600
-97% -$28M
HNST icon
2195
The Honest Company
HNST
$412M
$709K ﹤0.01%
235,542
-385,034
-62% -$1.2M
HHS icon
2196
Harte-Hanks
HHS
$16.4M
$709K ﹤0.01%
60,621
-9,431
-13% -$104K
MAIN icon
2197
Main Street Capital
MAIN
$5.05B
$707K ﹤0.01%
+19,142
New +$700K
CIIGW
2198
CALL
DELISTED
CIIG Capital Partners II, Inc. Warrant
CIIGW
$703K ﹤0.01%
68,956
-126,401
-65% -$8.34K
XSD icon
2199
State Street SPDR S&P Semiconductor ETF
XSD
$2.51B
$702K ﹤0.01%
+4,200
New +$702K
PBJ icon
2200
Invesco Food & Beverage ETF
PBJ
$111M
$702K ﹤0.01%
15,382
-1,011
-6% -$46.5K

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.